Sequana Medical announces the appointments of industry experts Pierre Chauvineau as Chairman and Wim Ottevaere as Non-Executive Director

Ghent, Belgium: 8 November 2018 - Sequana Medical nv, a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders, announces today the appointments of Pierre Chauvineau as Chairman and Wim Ottevaere as non-executive director of the Company effective as of the closing of the intended Initial Public Offering announced today. Pierre will succeed Rudy Dekeyser as Chairman, who will remain a non-executive director.

More info on Sequana's website.

Next > UK NICE recommends use of Sequana's alfapump® for the treatment of refractory ascites caused by cirrhosis under special arrangements

Previous > Capricorn’s Sustainable Chemistry Fund joins Black Bear funding round to solve the global waste tire problem and slash CO2